CIVERA, MONICA
 Distribuzione geografica
Continente #
EU - Europa 4.314
NA - Nord America 3.389
AS - Asia 2.064
SA - Sud America 162
OC - Oceania 28
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.984
Nazione #
US - Stati Uniti d'America 3.303
GB - Regno Unito 1.208
IT - Italia 916
CN - Cina 756
DE - Germania 703
SG - Singapore 436
SE - Svezia 416
RU - Federazione Russa 278
IN - India 251
TR - Turchia 163
FR - Francia 135
IE - Irlanda 134
BR - Brasile 112
KR - Corea 108
UA - Ucraina 106
FI - Finlandia 80
ID - Indonesia 75
HK - Hong Kong 74
NL - Olanda 73
JP - Giappone 70
CA - Canada 69
DK - Danimarca 58
EU - Europa 46
CO - Colombia 32
BE - Belgio 31
IR - Iran 27
AU - Australia 26
ES - Italia 26
LV - Lettonia 26
CH - Svizzera 23
GR - Grecia 23
PH - Filippine 18
RO - Romania 16
TW - Taiwan 14
PL - Polonia 13
MX - Messico 12
AT - Austria 11
BD - Bangladesh 11
CZ - Repubblica Ceca 10
EG - Egitto 10
MY - Malesia 10
VN - Vietnam 9
UZ - Uzbekistan 8
CL - Cile 7
HR - Croazia 6
PK - Pakistan 6
TH - Thailandia 6
IL - Israele 5
SC - Seychelles 5
EC - Ecuador 4
MA - Marocco 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BO - Bolivia 3
CY - Cipro 3
KE - Kenya 3
LT - Lituania 3
PT - Portogallo 3
SI - Slovenia 3
DO - Repubblica Dominicana 2
JO - Giordania 2
KZ - Kazakistan 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 10.030
Città #
Southend 1.043
Chandler 408
Milan 390
Singapore 306
Seattle 245
Hanover 242
Fairfield 190
Princeton 174
Wilmington 171
Ashburn 169
Beijing 138
Ann Arbor 135
Dublin 131
Council Bluffs 122
Woodbridge 108
Dearborn 104
Mountain View 102
Houston 78
Nanjing 75
Cambridge 69
Phoenix 69
Redmond 66
Redwood City 63
Jacksonville 57
Toronto 53
Jakarta 52
Bengaluru 51
Des Moines 51
Santa Clara 47
Shanghai 44
Istanbul 42
Munich 42
Shenyang 39
Boardman 36
Medford 36
Somerville 36
Andover 34
Jinan 33
Sakarya 33
Eitensheim 32
Frankfurt am Main 31
Bogotá 30
Grafing 30
Hong Kong 29
Hangzhou 27
Mumbai 27
Tokyo 26
Guangzhou 25
Serra 24
Brussels 23
Tianjin 23
Nanchang 21
Berlin 20
Helsinki 20
Los Angeles 20
Hyderabad 19
Bologna 18
Pavia 17
Bitonto 16
Hamburg 16
Kent 16
Kwun Tong 16
Central 15
São Paulo 14
Izmir 13
Nuremberg 13
Odernheim 13
Portage 13
Pune 13
Turin 13
Barcelona 12
Changsha 12
Fuzhou 12
Hebei 12
Kiez 12
Napoli 12
Ningbo 12
San Diego 12
Athens 11
Bucharest 11
London 11
Fremont 10
Romola 10
Adelaide 9
Genoa 9
Norwalk 9
Nürnberg 9
Rome 9
Washington 9
Angered 8
Bühl 8
Dhaka 8
Dong Ket 8
Lanzhou 8
Piscataway 8
Bodio Lomnago 7
Boston 7
Como 7
Kuala Lumpur 7
Kunming 7
Totale 6.203
Nome #
Side chain effect in the modulation of αvβ3/α5β1 integrin activity via clickable isoxazoline-RGDmimetics: development of molecular delivery systems 392
Nature-inspired and medicinally relevant short peptides 312
Crystal structure of human E-cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interaction 308
New beta-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins 302
Insights into the Binding of Cyclic RGD Peptidomimetics to a5b1 Integrin by using Live-Cell NMR And Computational Studies 231
Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies 226
Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions 223
Molecular Dynamics Simulation of Aqueous Solutions of Trimethylamine-N-oxide and tert-Butyl Alcohol 222
On-Chip Screening of a Glycomimetic Library with C-Type Lectins Reveals Structural Features Responsible for Preferential Binding of Dectin-2 over DC-SIGN/R and Langerin 220
DENPOL: a program to determine ab initio quality electron densities for polypeptides 213
Unusual properties of aqueous solutions of L-Proline : a Molecular Dynamics study 194
Thermodynamically-Weighted Conformational Ensemble of Cyclic RGD Peptidomimetics from NOE Data 186
Relaxing and Transferring Extremely Localized Molecular Orbitals 184
Design and synthesis of peptidomimetic molecules targeting cadherin-mediated protein-protein interactions 176
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ 3 integrin ligands 164
Behavior of glycolylated sialoglycans in the binding pockets of murine and human CD22 163
RGD-based peptides targheting αIIbβ3 and αvβ3 integrin receptors: an NMR point of view 155
Potent integrin ligands containing a bifunctional diketopiperazine scaffold 152
Investigating the Interaction of Cyclic RGD Peptidomimetics with αVβ6 Integrin by Biochemical and Molecular Docking Studies 152
Interpretazione microscopica dell’effetto osmoprotettivo della taurina mediante dinamica 147
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II : Structural and biological characterization 145
Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands 143
Extremely localized molecular orbitals : theory and applications 142
Synthesis of cyclic RGD peptidomimetics, containing a bifunctional diketopiperazine scaffold, as new integrin ligands 140
Molecular dynamics simulation of aqueous solutions of glycine betaine 139
Synthesis and Conformational Studies of Peptidomimetics Containing a New Bifunctional Diketopiperazine Scaffold Acting as a beta-Hairpin Inducer 138
Targeting protein-protein interactions in cancer with peptidomimetics: insights into ligand conformation and ligand-receptor interactions 137
Design and synthesis of potent integrin ligands containing a bifunctional diketopiperazine scaffold 132
STD and trNOESY NMR Study of Receptor-Ligand Interactions in Living Cancer Cells 132
Synthesis of Gd and [68Ga] complexes in conjugation with a conformationally-optimized RGD sequence as potential MRI and PET tumour-imaging probes 131
Molecular dynamics simulation of aqueous solutions of osmolytes 130
Targeting integrins alphaVbeta3 and alphaIIbeta3 with RGD peptidomimetics : study of the ligand conformation and of the ligand-receptor interactions 127
Modelling cadherin-mediated protein-protein interactions by atomistic simulations 127
Binding of RGD-peptide mimics to intact human platelets : an NMR study 126
New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics 125
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics : Insights from Computational Analyses and Implications for Molecular Design 125
Antiangiogenic Effect of Dual/Selective alpha5beta1/alphavbeta3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics. 124
PhthalaPhos : Chiral Supramolecular Ligands for Enantioselective Rhodium-Catalyzed Hydrogenation Reactions 124
Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting 121
Insights into molecular bases of cadherin : small ligands interaction by STD : NMR 121
GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro 120
A fragment-based virtual screening approach to identify e-cadherin lingands 120
Structure-Based Design of RSH inhibitors to Hamper persistence 120
Cyclic RGD-Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands 119
Different behavior of cyclic RGD peptidomimetics versus a5b1 and aVb3 integrin-rich cancer cells: NMR and computational analysis 114
The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin α v β 3 114
Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and αIIbβ3 integrin-rich intact cells by NMR and computational studies 113
PhthalaPhos : chiral supramolecular ligands for enantioselective hydrogenation reactions 112
A library approach to the development of chiral supramolecular ligands for asymmetric hydrogenation 112
Homology model of a catalytically competent bifunctional Rel protein 111
A Comprehensive NMR Analysis of the Interaction between DKP-RGD Ligands and Membrane Proteins on Intact Cells 110
Synthesis and conformational analysis of β-hairpin mimics containing bifunctional diketopiperazine scaffolds 108
New Chemotypes for the Inhibition of (p)ppGpp Synthesis in the Quest for New Antimicrobial Compounds 105
Bromine-promoted glycosidation of conformationally superarmed thioglycosides 102
Cyclic RGD and isoDGR Integrin Ligands Containing cis-2-amino-1-cyclopentanecarboxylic (cis-beta-ACPC) Scaffolds 102
Chemical and Biophysical Approaches to Allosteric Modulation 101
STD-NMR experiments on tumor cells to investigate RGD ligand - membrane protein interactions 100
Foldamers of bifunctional diketopiperazines displaying a beta-bend ribbon structure 97
Peptidomimetic inhibitors of cadherin homophilic interactions: from computational design to ligand binding epitope by STD NMR 97
Synthesis and conformational analysis of β-Harpin mimics containing bifunctional diketopiperazine scaffolds 95
Development of Isoxazoline-Containing Peptidomimetics as Dual alphaVbeta3 and alpha5beta1 Integrin Ligands 94
Cyclic RGD peptidomimetics: insights into the binding to integrin-rich cancer cells by NMR and computational studies 94
Rhodium-catalyzed asymmetric hydrogenation of olefins with phthalaphos, a new class of chiral supramolecular ligands 93
Bifunctional 2,5-Diketopiperazines as Efficient Organocatalysts for the Enantioselective Conjugate Addition of Aldehydes to Nitroolefins 92
A library approach to the development of BenzaPhos: Highly efficient chiral supramolecular ligands for asymmetric hydrogenation 92
An integrated computational and NMR study of the first peptidimimetic inhibitors of cadherin homophilic interaction 89
Computer-aided design of peptidomimetic molecules targeting cadherin-mediated protein-protein interactions 85
Reconstructing the free energy landscape of E-Cadherin conformational transition by metadynamics simulations 76
Structure based design of RSH inhibitors 72
Glycomimetic antagonists of BC2L-C lectin: insights from Molecular Dynamics simulations 69
Investigating the interaction of peptidomimetic ligands with e-cadherin using NMR and computational studies 66
A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands 65
New Insights into the molecular mechanism of E-cadherin-mediated cell adhesion by free energy calculations 65
Crystal structure of human E-cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interactions 59
Rhodium-Catalyzed Asymmetric Hydrogenation of Olefins with PhthalaPhos, a New Class of Chiral Supramolecular Ligands 56
Design of Cyclopeptidic Drugs 53
Conformationally Constrained Sialyl Analogues as New Potential Binders of h-CD22 51
Modulation of αvβ3- and α5β1-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics 50
Differential modulation of alphavbeta3 dynamics upon RGD-ligands 44
Tumor Carbohydrate Associated Antigen Analogs as Potential Binders for Siglec-7 42
Achieving high affinity for a bacterial lectin with reversible covalent ligands 22
Evolution of SARS-CoV-2 spike trimers towards optimized heparan sulfate cross-linking and inter-chain mobility 4
Tracking the interaction between α-Synuclein mutants and Tubulin Using DOSY (Diffusion Ordered Spectroscopy) NMR 3
Totale 10.559
Categoria #
all - tutte 31.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020440 0 0 0 0 0 0 0 0 186 150 57 47
2020/20211.104 103 99 79 34 96 70 93 83 102 124 154 67
2021/20221.252 74 66 51 59 106 135 130 90 133 90 108 210
2022/20231.359 170 138 138 147 140 233 26 92 143 29 60 43
2023/20241.032 30 87 71 65 190 81 65 79 43 100 94 127
2024/20251.446 111 231 62 227 150 134 117 263 151 0 0 0
Totale 10.559